Supplementary Online Content
|
|
- Marcia Ross
- 5 years ago
- Views:
Transcription
1 Supplementary Online Content Lewington S, Lacey B, Clarke R, et al; China Kadoorie Biobank Consortium. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. Published online March 14, doi: /jamainternmed emethods. Local, ational, and International Ethics Approvals of China Kadoorie Biobank etable 1. Prevalence of Isolated Systolic Hypertension and Isolated Diastolic Hypertension by Age and Sex etable 2. Prevalence of Stage 1 Hypertension and Stage 2 Hypertension, by Age and Sex etable 3. Prevalence, Diagnosis, Treatment and Control of Hypertension, by Age and Sex etable 4. Participants With Diagnosed Hypertension, Treated and Controlled, by Age and Sex etable 5. Proportion of Participants With Treated Hypertension Taking Specific Types of Antihypertensives, by Age and Sex etable 6. Participants With Diagnosed Hypertension, Treated and Controlled, by Selected Characteristics etable 7. Baseline Characteristics by Level of Baseline Systolic Blood Pressure This supplementary material has been provided by the authors to give readers additional information about their work.
2 emethods. Local, ational, and International Ethics Approvals of China Kadoorie Biobank For the baseline survey and 1st resurvey, ethics approval was obtained from the Chinese Center for Disease Control and Prevention Ethical Review Committee in 2004 and the University of Oxford Tropical Research Ethics Committee in The Chinese Ministry of Health approved the study at the start in 2004 (including export of plasma samples to Oxford), and also approved the electronic linkage to health insurance records in For the 2nd resurvey in , ethics approval was obtained from the Chinese Academy of Medical Sciences (which is now the formal collaborator of the China Kadoorie Biobank in China) Ethical Review Committee and the University of Oxford Tropical Research Ethics Committee in 2013.
3 etable 1. Prevalence of Isolated Systolic Hypertension and Isolated Diastolic Hypertension, by Age and Sex Hypertension (%) Isolated systolic Isolated diastolic Both Controlled Age at entry Population, SBP (mmhg): 140 < < 140 (years) DBP (mmhg): and < 90 and 90 and 90 and < 90 Male Female Both All Overall Hypertension defined as measured SBP 140 mmhg or measured DBP 90 mmhg or receiving treatment for hypertension. All analyses are standardized for region and, where appropriate, additionally standardized for age and sex.
4 etable 2. Prevalence of Stage 1 Hypertension and Stage 2 Hypertension, by Age and Sex Hypertension (%) Stage 1 Stage 2 Controlled Age at entry Population, SBP (mmhg): < 140 (years) DBP (mmhg): or or 100 and < 90 Male Female Both All Overall Hypertension defined as measured SBP 140 mmhg or measured DBP 90 mmhg or receiving treatment for hypertension. Stage 1 hypertension and stage 2 hypertension as defined in Seventh Report of the Joint ational Committee on Detection, Evaluation and Treatment of High Blood Pressure (participants classified by higher stage of either SBP or DBP). All analyses are standardized for region and, where appropriate, additionally standardized for age and sex.
5 etable 3. Prevalence, Diagnosis, Treatment and Control of Hypertension, by Age and Sex Age at entry (years) Male Population, Prevalence of hypertension, % Diagnosed among hypertensives, % Treated among diagnosed, % Among treated, % Controlled Among all hypertensives, % All Female All Both Overall
6 Hypertension defined as measured SBP 140 mmhg or measured DBP 90 mmhg or receiving treatment for hypertension. All analyses are standardized for region and, where appropriate, additionally standardized for age and sex. See etable 4 for numbers of participants in each group.
7 etable 4. Participants With Diagnosed Hypertension, Treated and Controlled, by Age and Sex Age at entry (years) Male Population, Hypertensives, Diagnosed, Treated, Controlled, All Female All Both Overall Hypertension defined as measured SBP 140 mmhg or measured DBP 90 mmhg or receiving treatment for hypertension.
8 etable 5. Proportion of Participants With Treated Hypertension Taking Specific Types of Antihypertensives, by Age and Sex % of treated hypertensives % of treated hypertensives (single antihypertensive medication only) Age at entry Treated Calcium Calcium hypertensives, ACE Beta- channel ACE Beta- channel (years) inhibitors blockers blockers Diuretics inhibitors blockers blockers Diuretics Any Male Female Both Overall Treated hypertensives were defined as those who reported being diagnosed with hypertension by a physician and taking antihypertensive medication at baseline.
9 etable 6. Participants With Diagnosed Hypertension, Treated and Controlled, by Selected Characteristics Characteristics Participants, Hypertensives, Diagnosed, Treated, Controlled, Region (type) Haikou (U) Sichuan (R) Liuzhou (U) Harbin (U) Hunan (R) Suzhou (U) Gansu (R) Qingdao (U) Henan (R) Zhejiang (R) Annual Household income, < Educational level o formal school Primary school Middle or high school Technical school or university Prior CVD o Yes Season b Winter Spring or Autumn Summer Overall Abbreviations: CVD, cardiovascular disease; R, rural; U, urban. a Defined as measured systolic blood pressure of at least 140 mm Hg, measured diastolic blood pressure of at least 90 mm Hg, or treatment for hypertension. b Season of baseline survey. Winter indicates December to February; spring, March to May; autumn, September to ovember; and summer, June to August.
10 etable 7. Baseline Characteristics by Level of Baseline Systolic Blood Pressure Systolic blood pressure (mmhg) < Mean (SD) SBP, mmhg 110 ( 7) 129 ( 6) 158 (16) Mean (SD) DBP, mmhg 69 ( 7) 78 ( 8) 88 (11) Mean (SD) age, years 48 ( 9) 51 (10) 57 (10) Proportion female, (%) (66) (55) (57) Proportion urban, (%) (50) (42) (41) Household income Yuan, (%) (44) (43) (42) Educated to middle school or higher, (%) (59) (50) (37) Current smokers, (%) (males only) (66) (62) (57) Alcohol at least weekly, (%) (males only) (29) (34) (36) Mean (SD) BMI, kg/m 2 23 ( 3) 24 ( 3) 25 ( 4) Fresh fruit consumed daily, (%) (23) (18) (16) Fresh vegetable consumed daily, (%) (95) (95) (95) Prior CVD, (%) ( 2) ( 4) ( 7) Proportion diabetic, (%) ( 2) ( 3) ( 5) Proportion taking statins, (%) 2 88 (0.1) 279 (0.1) 760 (0.5) Month of baseline survey: April to Sept, (%) (62) (50) (43) 1 In females, overall prevalence of current smokers was 2% (n=7003) and overall prevalence of drinking alcohol at least weekly was 2% (n=6124). 2 In those with prior CVD at baseline, overall prevalence of statin use was 1.4%.
Seasonal variation in blood pressure and its relationship with outdoor air temperature in 10 diverse regions of China: the China Kadoorie Biobank
Seasonal variation in blood pressure and its relationship with outdoor air temperature in diverse regions of China: the China Kadoorie Biobank SUPPLEMENTAL MATERIAL 1 Tables etable 1: Seasonal mean outdoor
More informationA loss-of-function variant in CETP and risk of CVD in Chinese adults
A loss-of-function variant in CETP and risk of CVD in Chinese adults Professor Zhengming CHEN Nuffield Dept. of Population Health University of Oxford, UK On behalf of the CKB collaborative group (www.ckbiobank.org)
More informationAssociation between multiple comorbidities and self-rated health status in middle-aged and elderly Chinese: the China Kadoorie Biobank study
Song et al. BMC Public Health (2018) 18:744 https://doi.org/10.1186/s12889-018-5632-1 RESEARCH ARTICLE Association between multiple comorbidities and self-rated health status in middle-aged and elderly
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More informationFindings- The sample contained participants with a mean age of 55 6 years (SD 9 7), 59 5% of whom were women. 44 7% (95% CI ) of
Prevalence, awareness, treatment, and control of hypertension in China: data from 1 7 million adults in a population-based screening study (China PEACE Million Persons Project) Jiapeng Lu*, Yuan Lu*, Xiaochen
More informationSupplementary Online Content
Supplementary Online Content Millwood IY, Bennett DA, Holmes MV, et al; China Kadoorie Biobank Collaborative Group. Association of CETP gene variants with risk for vascular and nonvascular diseases among
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationSupplementary Online Content
Supplementary Online Content Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open. 2018;1(4):e181271. doi:10.1/jamanetworkopen.2018.1271
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationTrends In CVD, Related Risk Factors, Prevention and Control In China
Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology
More informationSeason and outdoor temperature in relation to detection and control of hypertension in a large rural Chinese population
International Journal of Epidemiology, 2014, 1835 1845 doi: 10.1093/ije/dyu158 Advance Access Publication Date: 18 August 2014 Original article Original article Season and outdoor temperature in relation
More informationIs there a mechanism of interaction between hypertension and dyslipidaemia?
Is there a mechanism of interaction between hypertension and dyslipidaemia? Neil R Poulter International Centre for Circulatory Health NHLI, Imperial College London Daegu, Korea April 2005 Observational
More informationSupplementary Online Content
Supplementary Online Content Song Z, Ayanian JZ, Wallace J, He Y, Gibson TB, Chernew ME. Unintended consequences of eliminating Medicare payments for consultations. JAMA Intern Med. Published online November
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationEvolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)
Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More informationBlood Pressure Acre Surgery Diviash Thakrar
Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise
More informationSupplementary Online Content
Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationArticles. Copyright 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0 5 million adults in China: a prospective cohort study Ben Lacey*, Sarah Lewington*, Robert Clarke*, Xiang
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationFresh Fruit Consumption and Major Cardiovascular Disease in China
The new england journal of medicine Original Article Fresh Fruit Consumption and Major Cardiovascular Disease in China Huaidong Du, Ph.D., Liming Li, M.D., M.P.H., Derrick Bennett, Ph.D., Yu Guo, M.Sc.,
More informationSupplementary Online Content
Supplementary Online Content Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. Published online February
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationSupplementary Online Content
Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Supplemental Table 1. Distribution of Participants Characteristics by Treatment Group at Baseline - The Vitamin D and calcium (CaD) Trial of the Women s Health Initiative (WHI) Study,
More informationSupplementary Online Content
Supplementary Online Content Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older
More informationSpotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound
Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationQuality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care
Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate
More informationParenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals
Diabetologia (2016) 59:1675 1682 DOI 10.1007/s00125-016-3980-x ARTICLE Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals Sanne A. E. Peters 1 &
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of men and women in China
Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 5 men and women in China Iona Y Millwood*, Robin G Walters*, Xue W Mei, Yu Guo, Ling Yang, Zheng Bian,
More informationThe Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4)
The Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4) Denis Xavier MD, MSc Professor and Head, Pharmacology, St. John's Medical College Coordinator, Division
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationImplementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care
Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care Shari Bolen MD, MPH MetroHealth/Case Western Reserve University 1 Disclosure
More informationNone. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) James W. Shaw, MD Memorial Lecture
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationHypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program
Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationBlood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More informationAdiposity and blood pressure among relatively lean rural adults in southwest of China
OPEN Journal of Human Hypertension (2015), 1 8 2015 Macmillan Publishers Limited All rights reserved 0950-9240/15 www.nature.com/jhh ORIGINAL ARTICLE Adiposity and blood pressure among 55 000 relatively
More informationNew Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets
New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationHypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care
Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider
More informationSupplementary Online Content
Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationSummary of recommendations
Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationGATEWAY Trial. Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension
GATEWAY Trial Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More information2017 High Blood Pressure Clinical Practice Guideline
2017 High Blood Pressure Clinical Practice Guideline Applying the Latest Hypertension Guideline to Your Practice Carmine D Amico, D.O., F.A.C.C. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH /
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More informationDifferent worlds, different tasks for health promotion: comparisons of health risk profiles in Chinese and Finnish rural people
HEALTH PROMOTION INTERNATIONAL Vol. 16, No. 4 Oxford University Press 2001. All rights reserved Printed in Great Britain Different worlds, different tasks for health promotion: comparisons of health risk
More informationThe Hypertension Clinic is a part of the Internal Medicine
Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationProf. Renata Cífková, MD, CSc.
Prof. Renata Cífková, MD, CSc. Head of the Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague Focuses on arterial hypertension epidemiology, clinical trials, target organ damage prevention
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationWhich antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017
Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 The most important reason for treating hypertension in primary care is to prevent
More informationEffects of smoking and smoking cessation on productivity in China
Effects of smoking and smoking cessation on productivity in China Team *Hong Wang; MD, PhD **Heng-Fu Zou; PhD I. Introduction *: Yale University; **: World Bank 1. Aim of Project We will study smoking
More informationHypertension in Clinical Practice. Abeer Al Saweer, MBBS, Arab Board*
1 Bahrain Medical Bulletin, Vol. 33, No. 1, March 2011 Education-Family Physician Corner Hypertension in Clinical Practice Abeer Al Saweer, MBBS, Arab Board* The global incidence of hypertension is growing.
More informationBlood Pressure Management in Acute Ischemic Stroke
Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationAbsolute cardiovascular disease risk management
Quick reference guide for health professionals Absolute cardiovascular disease risk management This quick reference guide is for use by health professionals for primary prevention of cardiovascular disease
More informationAlcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3./), which permits non-commercial re-use,
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More informationNew Hypertension Guidelines. Kofi Osei, MD
New Hypertension Guidelines Kofi Osei, MD None Disclosures Objectives The new blood pressure definitions and cardiovascular risk The role to time and location in the diagnosis of hypertension Apply evidence-based
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationA fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational
Hostalek U et al. Medical Research Archives, vol. 5, issue 11, November 2017 issue Page 1 of 11 RESEARCH ARTICLE A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension:
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationUnderstanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s
Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based
More informationBranko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center
Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center THE END! CHANGABLE Blood pressure Diabetes Mellitus Hyperlipidemia Atrial fibrillation Nicotine Drug abuse Life style NOT CHANGABLE
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationSupplementary Online Content
Supplementary Online Content Schulz Schüpke S, Helde S, Gewalt S; et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical
More informationmajor public health burden
HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing
More informationRenal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.
Renal Disease through the Ages: From Childbearing years to Old Age Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Learning Outcomes: Understand the presentation of renal
More informationGuidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals
Guidelines for Integrated Management of Cardiovascular Diseases and Diabetes in Clinics and Ri-hospitals Ministry of Public Health DPR Korea January 2013 Rationale ncommunicable diseases such as cardiovascular
More informationAquifer Hypertension Guidelines Module
Aquifer Hypertension Guidelines Module 2018 Aquifer Hypertension Guidelines Module 1 1. Introduction. In 2013 the National Heart Lung and Blood Institute (NHLBI) asked the American College of Cardiology
More informationEFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION
EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION Khemchandani D. 1 and * Arif A. Faruqui 2 1 Bairagarh,
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationManagement of Lipid Disorders and Hypertension: Implications of the New Guidelines
Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine
More informationWhat is Hypertension?
Hypertension What is Hypertension? Hypertension is also called high blood pressure It can be written as HBP or HTN Blood Pressure measures the force against the walls of your arteries as your heart pumps
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More information